The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review
Background Smoking is the number one cause of preventable morbidity and mortality globally and although many countries have invested heavily in smoking cessation programs, 21% of the global population still smoke. Post cessation weight gain has been identified as a barrier to attempting cessation an...
| Published in: | Journal of Pharmaceutical Policy and Practice |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-12-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1186/s40545-017-0109-7 |